In conclusion, both the Pan-Immune Inflammation Value (PIV) and the C-reactive protein–albumin–lymphocyte (CALLY) index serve as robust prognostic biomarkers in both ischemic and hemorrhagic strokes by integrating inflammatory, immunological, and nutritional axes. The gene discussed is CRP; the disease is hemorrhagic stroke.